A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Non-fasting Conditions

NCT00863863 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Griseofulvin 125 mg/5 mL Suspension, single dose
DRUG: Grifulvin V® 125 mg/5 mL Suspension, single dose

Sponsor

Actavis Inc.